Jacalin Attenuates Colitis-Associated Colorectal Carcinogenesis by Inhibiting Tumor Cell Proliferation and Intestinal Inflammation
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Luciana Chain Veronez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Basic and Applied Immunology, Biochemistry and Immunology Department, Ribeirão Preto Medical School, University of São Paulo, Rib…. Hauptthemen laut MEDLINE: Cell Proliferation, Colitis-Associated Neoplasms, Plant Lectins, Colitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) remains a significant cause of morbidity and mortality worldwide. In patients with inflammatory bowel disease, who have twice the risk of developing CRC, chronic inflammation has been recognized to contribute to colitis-associated cancer (CAC) development. Jacalin, a lectin extracted from jackfruit seeds, has been shown to recognize altered glycosylation and to exert antiproliferative and cytotoxic effects in CRC. However, its activity in CAC remains unknown. Herein, we sought to investigate the effects of jacalin in CAC progression using the dextran sulfate sodium (DSS) and azoxymethane (AOM) mouse model.
Methods
Colitis-associated cancer induction was performed in male C57BL/6 mice by an intraperitoneal injection of AOM, followed by 3 cycles of 2.5% DSS diluted in drinking water for 7 days, intercalated by 2 weeks of normal drinking water. After 1 week of daily pretreatment, mice were orally treated with phosphate-buffered saline (control group), 100 or 500 µg of jacalin three times a week for an additional 11 weeks.
Results
We showed that jacalin-treated mice presented tumors with reduced volumes and mean size compared to the control group. In addition, both doses of jacalin reduced the number of proliferating cells (Ki-67 positive cells) in tumor tissues, while the higher dose (500 µg) showed also a similar effect in “normal-appearing” colonic crypts. Jacalin treatment attenuated the clinical scores of inflammations, which was accompanied by a reduction of intestinal and/or tumoral production of IL-1β, IL-23, and IL-17.
Conclusions
Collectively, our findings demonstrated that jacalin suppresses CAC development, highlighting its anti-inflammatory and antitumoral role in the AOM/DSS-induced model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Basic and Applied Immunology, Biochemistry and Immunology Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo 14040-902, Brazil.
- Nursing Department, Health Sciences Center, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil.
- Structural and Functional Biology Department, São Paulo State University (UNESP), Institute of Biosciences, Botucatu, São Paulo 18618-689, Brazil.
- Maternal-Infant and Public Health Nursing Department, Ribeirão Preto School of Nursing, University of São Paulo, Ribeirão Preto, São Paulo 14040-902, Brazil.
ORCID-Profile: Luciana Chain Veronez, Denise Sayuri Calheiros da Silveira, Luis Carlos Lopes-Júnior
Zitieren
APA
Veronez, L. C., Silveira, D. S. C. D., Lopes-Júnior, L. C., Dos Santos, J. C., Barbisan, L. F., & Pereira-da-Silva, G. (2025). Jacalin Attenuates Colitis-Associated Colorectal Carcinogenesis by Inhibiting Tumor Cell Proliferation and Intestinal Inflammation. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae303
Vancouver
Veronez LC, Silveira DSCD, Lopes-Júnior LC, Dos Santos JC, Barbisan LF, Pereira-da-Silva G. Jacalin Attenuates Colitis-Associated Colorectal Carcinogenesis by Inhibiting Tumor Cell Proliferation and Intestinal Inflammation. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae303
BibTeX
@article{Veronez2025,
author = {Veronez, Luciana Chain and Silveira, Denise Sayuri Calheiros da and Lopes-Júnior, Luis Carlos and Dos Santos, Jéssica Cristina and Barbisan, Luis Fernando and Pereira-da-Silva, Gabriela},
title = {Jacalin Attenuates Colitis-Associated Colorectal Carcinogenesis by Inhibiting Tumor Cell Proliferation and Intestinal Inflammation},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae303}
}
EUVIMED